Rhythm Pharmaceuticals (RYTM) earnings, Aug 4, 2026: EPS +3%, stock +4.7%
In brief
Rhythm Pharmaceuticals reported on Aug 4, 2026. Earnings per share changed +3% year over year, 9.6% above the estimate; revenue +47%. The stock opened with a +4.8% gap and closed the day +4.7% (Aug 5, 2026). The stock is now 14.1% below its 52-week high, +5.6% over 12 months. Next report: Mar 3, 2027.
EPS vs estimate+9.6%
EPS, YoY+3%
Revenue, YoY+47%
Gap · day+4.8% · +4.7%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 4, 2026 | +4.8% | +4.7% |
Next-quarter estimates, ratings and the RYTM chart are in the terminal.
Open the terminalFAQ
When is Rhythm Pharmaceuticals's next earnings report?
Mar 3, 2027. The date comes from daily data and is corrected if the company moves it.
How did Rhythm Pharmaceuticals stock react to the report?
Opening gap +4.8%, day's result +4.7%.
Did Rhythm Pharmaceuticals's earnings grow?
Earnings per share rose 3% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.